Bayer HealthCare Licenses MedScan™ Text-to-Knowledge Suite by Ariadne Genomics
Ariadne Genomics, Inc. today announced that Bayer HealthCare AG has licensed its MedScan™ Text-to-Knowledge Suite for development of an internal molecular interaction database. MedScan extracts pathway-related facts from scientific literature with state-of-the-art natural language processing technology.
"MedScan is high performance tool for automated extraction of pathway-related information from TXT, HTML, PDF and MS Office files; catalogs and archives. Extracted facts, ranging from regulation, expression or binding to molecular transport, protein modification and molecular synthesis are stored in XML files," said Nikolai Daraselia, Director of Research at Ariadne Genomics. "MedScan easily integrates with other bioinformatics software, and can be configured for automatic daily activity, for example, PubMed updates processing."
"Bayer HealthCare recognizes the importance of using pathway analysis tools for interpretation of experimental results and hypotheses validation. But to make these tools truly efficient, we need an internal integrated database of pathways and molecular networks, containing all most recent information," said Michael Seewald, Bioinformatician at Bayer HealthCare AG. "We have chosen MedScan for its advanced natural language processing algorithm, well known for high recovery rate and accuracy, and its ease of integration with our bioinformatics systems."
Article Pages: 1
Article CommentsAdd Comment |
View All(0)
There are currently no comments for this article.